Levonorgestrel butyrate

• CAT Number: I030723
• CAS Number: 86679-33-6
• Molecular Formula: C25H34O3
• Molecular Weight: 382.54
• Purity: 98%
• Synonyms: Levonorgestrel butyrate
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: [(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] butanoate
• InChI: InChI=1S/C25H34O3/c1-4-7-23(27)28-25(6-3)15-13-22-21-10-8-17-16-18(26)9-11-19(17)20(21)12-14-24(22,25)5-2/h3,16,19-22H,4-5,7-15H2,1-2H3/t19-,20+,21+,22-,24-,25-/m0/s1
• InChIKey: GPKLGCALNRZIDS-AYEDEZQKSA-N
• SMILES: CCCC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)CC)C#C

Levonorgestrel butyrate（Cat No.:I030723）is an ester derivative of levonorgestrel, a synthetic progestin commonly used in contraceptives. This modified form combines levonorgestrel with butyric acid to potentially improve its pharmacokinetic properties, such as solubility, bioavailability, and duration of action. Levonorgestrel is effective in preventing pregnancy by inhibiting ovulation, altering the endometrial lining, and thickening cervical mucus. Levonorgestrel butyrate is being explored for use in extended-release contraceptives or other hormonal therapies, with research focused on optimizing its effectiveness, safety profile, and potential applications in reproductive health and hormone-related treatments.

Reference

1: Gan L, Jiang X, Mendonza A, Swan T, Reynolds C, Nguyen J, Pal P, Neelakantham S, Dahlke M, Langenickel T, Rajman I, Akahori M, Zhou W, Rebello S, Sunkara G. Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects. Clin Pharmacol Drug Dev. 2016 Jan;5(1):27-39. doi: 10.1002/cpdd.181. Epub 2015 Nov 4. PubMed PMID: 27119576.
2: Steenbergen L, Sellaro R, Stock AK, Beste C, Colzato LS. γ-Aminobutyric acid (GABA) administration improves action selection processes: a randomised controlled trial. Sci Rep. 2015 Jul 31;5:12770. doi: 10.1038/srep12770. PubMed PMID: 26227783; PubMed Central PMCID: PMC4521208.
3: Minuti A, Palladino A, Khan MJ, Alqarni S, Agrawal A, Piccioli-Capelli F, Hidalgo F, Cardoso FC, Trevisi E, Loor JJ. Abundance of ruminal bacteria, epithelial gene expression, and systemic biomarkers of metabolism and inflammation are altered during the peripartal period in dairy cows. J Dairy Sci. 2015 Dec;98(12):8940-51. doi: 10.3168/jds.2015-9722. Epub 2015 Sep 26. PubMed PMID: 26409956.
4: Bartoli A, Gatti G, Cipolla G, Barzaghi N, Veliz G, Fattore C, Mumford J, Perucca E. A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers. Epilepsia. 1997 Jun;38(6):702-7. PubMed PMID: 9186253.
5: Shulga A, Rivera C. Interplay between thyroxin, BDNF and GABA in injured neurons. Neuroscience. 2013 Jun 3;239:241-52. doi: 10.1016/j.neuroscience.2012.12.007. Epub 2012 Dec 13. Review. PubMed PMID: 23246615.
6: Meseguer-Lloret S, Torres-Cartas S, Catalá-Icardo M, Gómez-Benito C. Selective and Sensitive Chemiluminescence Determination of MCPB: Flow Injection and Liquid Chromatography. Appl Spectrosc. 2016 Feb;70(2):312-21. doi: 10.1177/0003702815620133. Epub 2015 Dec 23. PubMed PMID: 26903566.
7: Greque de Morais M, Greque de Morais E, Vaz Bda S, Gonçalves CF, Lisboa C, Costa JA. Nanoencapsulation of the Bioactive Compounds of Spirulina with a Microalgal Biopolymer Coating. J Nanosci Nanotechnol. 2016 Jan;16(1):81-91. Review. PubMed PMID: 27398435.
8: Liu TT, Tseng YW, Yang TS. Functionalities of conjugated compounds of γ-aminobutyric acid with salicylaldehyde or cinnamaldehyde. Food Chem. 2016 Jan 1;190:1102-1108. doi: 10.1016/j.foodchem.2015.06.077. Epub 2015 Jun 23. PubMed PMID: 26213082.
9: Williamson J, Eilon LA, Walker SR. Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure. Trans Ophthalmol Soc U K. 1981;101(1):27-9. PubMed PMID: 6764318.
10: Lengler J, Jug F, Steger A. Reliable neuronal systems: the importance of heterogeneity. PLoS One. 2013 Dec 4;8(12):e80694. doi: 10.1371/journal.pone.0080694. eCollection 2013. PubMed PMID: 24324621; PubMed Central PMCID: PMC3851464.
11: Rusy LM, Hainsworth KR, Nelson TJ, Czarnecki ML, Tassone JC, Thometz JG, Lyon RM, Berens RJ, Weisman SJ. Gabapentin use in pediatric spinal fusion patients: a randomized, double-blind, controlled trial. Anesth Analg. 2010 May 1;110(5):1393-8. doi: 10.1213/ANE.0b013e3181d41dc2. PubMed PMID: 20418301.
12: Lo HS, Yang CM, Lo HG, Lee CY, Ting H, Tzang BS. Treatment effects of gabapentin for primary insomnia. Clin Neuropharmacol. 2010 Mar-Apr;33(2):84-90. doi: 10.1097/WNF.0b013e3181cda242. PubMed PMID: 20124884.
13: Pan CJ, Sartwell AD, Chou JY. Transcriptional regulation and the effects of sodium butyrate and glycosylation on catalytic activity of human germ cell alkaline phosphatase. Cancer Res. 1991 Apr 15;51(8):2058-62. PubMed PMID: 2009524.
14: Torkkeli PH, Meisner S, Pfeiffer K, French AS. GABA and glutamate receptors have different effects on excitability and are differentially regulated by calcium in spider mechanosensory neurons. Eur J Neurosci. 2012 Dec;36(12):3602-14. doi: 10.1111/j.1460-9568.2012.08275.x. Epub 2012 Aug 29. PubMed PMID: 22928994.
15: Trombold JR, Christmas KM, Machin DR, Kim IY, Coyle EF. Acute high-intensity endurance exercise is more effective than moderate-intensity exercise for attenuation of postprandial triglyceride elevation. J Appl Physiol (1985). 2013 Mar 15;114(6):792-800. doi: 10.1152/japplphysiol.01028.2012. Epub 2013 Jan 31. PubMed PMID: 23372145.
16: Floryszak-Wieczorek J, Arasimowicz-Jelonek M, Milczarek G, Janus L, Pawlak-Sprada S, Abramowski D, Deckert J, Billert H. Nitric oxide-mediated stress imprint in potato as an effect of exposure to a priming agent. Mol Plant Microbe Interact. 2012 Nov;25(11):1469-77. doi: 10.1094/MPMI-02-12-0044-R. PubMed PMID: 22835274.
17: Cal M, Jaremko M, Jaremko Ł, Stefanowicz P. One-pot efficient synthesis of N(α)-urethane-protected β- and γ-amino acids. Amino Acids. 2013 Mar;44(3):1085-91. doi: 10.1007/s00726-012-1443-3. Epub 2012 Dec 19. PubMed PMID: 23250684; PubMed Central PMCID: PMC3569585.
18: Neymotin SA, Jacobs KM, Fenton AA, Lytton WW. Synaptic information transfer in computer models of neocortical columns. J Comput Neurosci. 2011 Feb;30(1):69-84. doi: 10.1007/s10827-010-0253-4. Epub 2010 Jun 17. PubMed PMID: 20556639; PubMed Central PMCID: PMC2997390.
19: Smith SW, Zvosec DL, Apple FS. Beta-hydroxybutyrate assay does not cross-react with gamma-hydroxybutyrate. Ann Emerg Med. 2002 Aug;40(2):258-9. PubMed PMID: 12140509.
20: Singh BM, Nutter SA, Nattrass M. Metabolic effects of combined oral contraceptive preparations. Contraception. 1987 Dec;36(6):651-8. PubMed PMID: 3128428.